Portugal – Pharmaceutical products – 2025/1627 - MACITENTANO [10 MG CÁP/COMP]

Unidade Local De Saúde Santa Maria, E.p.e. · Portugal government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

$182,153
Est. Value
Active
Status

About this record

The issuing agency did not publish a description for this notice. The full record as GlobalGov received it is below.

This is one of 43 active Portugal Pharmaceuticals opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyUnidade Local De Saúde Santa Maria, E.p.e.
CountryPortugal
CategoryPharmaceuticals
Estimated value$182,153
PublishedSeptember 08, 2026
Procurement stageRequest for Proposal (RFP)
Response dueNot specified / rolling
StatusOpen — accepting responses
TranslationTranslated from Portuguese by GlobalGov’s translation pipeline
Official sourceView original notice
Last verifiedOctober 04, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Related Opportunities in Portugal

Portugal – Pharmaceutical products – C/ BASE NO CPA 2023_481 - AXICABTAGENE CILOLEUCEL 0.4 - 2 X10E8 CÉLULAS DISP INJ FR 68 ML IV
Portugal – Pharmaceutical products – 2023/0491 - OFATUMUMAB [20 MG/0.4 ML SOL INJ CANETA]
Portugal – Pharmaceutical products – 2026/0098 - ELIGLUSTATO [84 MG CÁP/ COMP]
Portugal – Pharmaceutical products – 2023/0491 - AVELUMAB [20 MG/ ML 10 ML FRS]
Portugal – Pharmaceutical products – 2023/0491 - RUXOLITINIB [5 MG CÁP/ COMP]
Portugal – Pharmaceutical products – 2024/0900 - DARUNAVIR + COBICISTATE [800 MG + 150 MG CÁP/ COMP]
Portugal – Pharmaceutical products – 2024/0899 - BENRALIZUMAB [30 MG/1 ML SOL INJ CANETA/ SERINGA]
Portugal – Pharmaceutical products – 2025/1627 - MACITENTANO [10 MG CÁP/COMP]

See every Portugal Pharmaceuticals opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Portugal Pharmaceuticals intelligence report in your inbox

A personalized report on Portugal Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.